首页> 外文期刊>Tissue antigens. >Mono-allelic amplification of exons 2-4 using allele group-specific primers for sequence-based typing (SBT) of the HLA-A, -B and -C genes: Preparation and validation of ready-to-use pre-SBT mini-kits.
【24h】

Mono-allelic amplification of exons 2-4 using allele group-specific primers for sequence-based typing (SBT) of the HLA-A, -B and -C genes: Preparation and validation of ready-to-use pre-SBT mini-kits.

机译:使用等位基因组特异性引物对HLA-A,-B和-C基因进行基于序列分型(SBT)的外显子2-4的单等位基因扩增:即用型SBT mini-的准备和验证套件。

获取原文
获取原文并翻译 | 示例
           

摘要

Class I allelic typing based on sequencing is reliable, immutable and easy to analyse when only one allele is amplified using a specific mono-allelic technique. A strategy has been developed to selectively amplify exons 2, 3 and 4 of each allele of the three class I loci, previously identified by generic typing, in order to sequence these alleles from their intronic parts in only one direction. This procedure is based mainly on the polymorphism of exon 1 and intron 1 of the HLA-A, -B and -C genes with allele group-specific forward primers and locus-specific reverse primers so as to perform mono-allelic amplification in a 'One Step' pre-sequence-based typing (pre-SBT) PCR. The 5' polymorphism found at each locus is nevertheless not sufficient to discriminate all allelic combinations. Hence exon 2 and exon 3 polymorphism had to be used in a 'Two Step' pre-SBT PCR method to selectively amplify the two alleles in the 1.8%, 7.6% and 0.9% of unresolved combinations found in our laboratory for, respectively, the HLA-A, -B and -C loci. Preparation and validation of 'ready-to-use' aliquots of primer-mixes, pre-SBT buffer and sets of Dye terminator reaction mixtures containing locus-specific intronic primers makes the procedure easy and efficient. The SBT method is the only allelic typing technique used in our laboratory (to date, 742 HLA-A*, 802 HLA-B* and 615 HLA-Cw* alleles have been sequenced) and our successful participation in the national and international quality controls of 4 years ago testifies to the accuracy of the results.
机译:当使用特定的单等位基因技术仅扩增一个等位基因时,基于测序的I类等位基因分型可靠,不变且易于分析。已经开发了一种策略,以选择性地扩增先前通过通用分型鉴定的三个I类基因座的每个等位基因的外显子2、3和4,以便仅在一个方向上从其内含子部分对这些等位基因进行测序。该程序主要基于HLA-A,-B和-C基因外显子1和内含子1与等位基因组特异性正向引物和基因座特异性反向引物的多态性,以便在' “一步式”基于序列的分型(pre-SBT)PCR。但是,在每个基因座处发现的5'多态性不足以区分所有等位基因组合。因此,必须在“两步法”前SBT PCR方法中使用外显子2和外显子3的多态性,以分别扩增实验室中未解析组合的1.8%,7.6%和0.9%的两个等位基因。 HLA-A,-B和-C位点。引物混合物,SBT前缓冲液和含有特定位点内含子引物的染料终止剂反应混合物组的“即用型”等分试样的制备和验证使该过程变得简单而有效。 SBT方法是我们实验室中使用的唯一等位基因分型技术(迄今为止,已对742 HLA-A *,802 HLA-B *和615 HLA-Cw *等位基因进行了测序),并且我们成功参与了国家和国际质量控制4年前的证明证明了结果的准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号